David T. Hagerty

2014

In 2014, David T. Hagerty earned a total compensation of $924.6K as Executive Vice President, Clinical Development at Conatus Pharmaceuticals.

Compensation breakdown

Option Awards$829,973
Salary$94,000
Other$623
Total$924,596

Hagerty received $830K in option awards, accounting for 90% of the total pay in 2014.

Hagerty also received $94K in salary and $623 in other compensation.

Rankings

In 2014, David T. Hagerty's compensation ranked 7,954th out of 13,032 executives tracked by ExecPay. In other words, Hagerty earned more than 39.0% of executives.

ClassificationRankingPercentile
All
7,954
out of 13,032
39th
Division
Manufacturing
2,944
out of 4,966
41st
Major group
Chemicals And Allied Products
1,000
out of 1,686
41st
Industry group
Drugs
783
out of 1,365
43rd
Industry
Pharmaceutical Preparations
609
out of 1,043
42nd
Source: SEC filing on April 28, 2015.

Hagerty's colleagues

We found two more compensation records of executives who worked with David T. Hagerty at Conatus Pharmaceuticals in 2014.

2014

Steven Mento

Conatus Pharmaceuticals

Chief Executive Officer

2014

Alfred Spada

Conatus Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like